Springer Nature OA
open access
CC BY-NC-ND 4.0
GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Replication Data for: GLP1-E2 Therapy Delays Autoimmune Diabetes in Late-stage Prediabetic NOD Mice and Potentiates Low-dose Anti-CD3 Therapy for Enhanced Disease Protection#231862
- Diabetes Autoimmunity Withdrawn in New Onset Patients (DAWN)#902441
- The Exploreration of the Management for the Positive IAA in Patients With Type 2 Diabetes After Premix Insulin Therapy#651200
- Randomized Controlled Trial of Insulin Versus Tablets for Latent Autoimmune Diabetes in Adults (LADA)#136233
- Mechanism Underlying Beta-cell Failure in Obese African Americans With History of Hyperglycemic Crises#803289
Record · ID 319403
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive